Effect of intravenous alanine on blood glucose, glucagon and growth hormone levels in diabetic children

G. Soltész, D. Molnár, J. Mestyan

Research output: Contribution to journalArticle

Abstract

To study its glycemic effect and to evaluate alpha cell function, L-alanine was administered intravenously (0.15 g/kg b.w.) to ketotic diabetic children. Their preinfusion condition was characterized by hyperglycemia, elevated alanine, glucagon and growth hormone levels. Alanine failed to cause a further increase in the plasma glucagon level and had no glycemic effect, but induced a consistent rise in plasma growth hormone. It is concluded that, in contrast with adult diabetics, alanine had no glycemic effect and was not a potent alpha-cell secretagogue in ketotic diabetic children. The demonstrated growth-hormone provoking effect suggests that endogenous hyperalaninemia may contribute to ketosis via the anti-insulin effect of growth hormone.

Original languageEnglish
Pages (from-to)195-200
Number of pages6
JournalActa Paediatrica Academiae Scientiarum Hungaricae
Volume23
Issue number2
Publication statusPublished - 1982

Fingerprint

Glucagon
Alanine
Growth Hormone
Blood Glucose
Ketosis
Hyperglycemia
Insulin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{d937f050cad84751af5db79f059641ff,
title = "Effect of intravenous alanine on blood glucose, glucagon and growth hormone levels in diabetic children",
abstract = "To study its glycemic effect and to evaluate alpha cell function, L-alanine was administered intravenously (0.15 g/kg b.w.) to ketotic diabetic children. Their preinfusion condition was characterized by hyperglycemia, elevated alanine, glucagon and growth hormone levels. Alanine failed to cause a further increase in the plasma glucagon level and had no glycemic effect, but induced a consistent rise in plasma growth hormone. It is concluded that, in contrast with adult diabetics, alanine had no glycemic effect and was not a potent alpha-cell secretagogue in ketotic diabetic children. The demonstrated growth-hormone provoking effect suggests that endogenous hyperalaninemia may contribute to ketosis via the anti-insulin effect of growth hormone.",
author = "G. Solt{\'e}sz and D. Moln{\'a}r and J. Mestyan",
year = "1982",
language = "English",
volume = "23",
pages = "195--200",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Effect of intravenous alanine on blood glucose, glucagon and growth hormone levels in diabetic children

AU - Soltész, G.

AU - Molnár, D.

AU - Mestyan, J.

PY - 1982

Y1 - 1982

N2 - To study its glycemic effect and to evaluate alpha cell function, L-alanine was administered intravenously (0.15 g/kg b.w.) to ketotic diabetic children. Their preinfusion condition was characterized by hyperglycemia, elevated alanine, glucagon and growth hormone levels. Alanine failed to cause a further increase in the plasma glucagon level and had no glycemic effect, but induced a consistent rise in plasma growth hormone. It is concluded that, in contrast with adult diabetics, alanine had no glycemic effect and was not a potent alpha-cell secretagogue in ketotic diabetic children. The demonstrated growth-hormone provoking effect suggests that endogenous hyperalaninemia may contribute to ketosis via the anti-insulin effect of growth hormone.

AB - To study its glycemic effect and to evaluate alpha cell function, L-alanine was administered intravenously (0.15 g/kg b.w.) to ketotic diabetic children. Their preinfusion condition was characterized by hyperglycemia, elevated alanine, glucagon and growth hormone levels. Alanine failed to cause a further increase in the plasma glucagon level and had no glycemic effect, but induced a consistent rise in plasma growth hormone. It is concluded that, in contrast with adult diabetics, alanine had no glycemic effect and was not a potent alpha-cell secretagogue in ketotic diabetic children. The demonstrated growth-hormone provoking effect suggests that endogenous hyperalaninemia may contribute to ketosis via the anti-insulin effect of growth hormone.

UR - http://www.scopus.com/inward/record.url?scp=0020427095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020427095&partnerID=8YFLogxK

M3 - Article

C2 - 6814169

AN - SCOPUS:0020427095

VL - 23

SP - 195

EP - 200

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 2

ER -